HASSAN FRED

Director at Cocrystal Pharma, Inc. · on record since Apr 27, 2023
Director at Merck & Co., Inc. · on record since May 23, 2006
Chairman and CEO at Merck & Co., Inc. · on record since May 23, 2006
Director at AVON PRODUCTS INC · on record since May 8, 2006
Director at PRECIGEN, INC. · on record since Jul 13, 2016
Director at EyePoint, Inc. · on record since Sep 5, 2024
Director at WARNER MEDIA, LLC · on record since Oct 30, 2009
Director at ELECTRONIC DATA SYSTEMS CORP /DE/ · on record since Oct 29, 2003
Director at Prometheus Biosciences, Inc. · on record since May 17, 2021
Director at VALEANT PHARMACEUTICALS INTERNATIONAL · on record since Aug 23, 2013
Director at AMGEN INC · on record since Jul 30, 2015
Director at BridgeBio Pharma, Inc. · on record since Aug 26, 2021

Insider trading activity of HASSAN FRED

Transactions on record: 196; since Dec 1, 2003

Open-market buys: 27; $14.7M

Open-market sells: 0

Companies traded: 10; last filing Jun 24, 2026

Figures computed from official regulatory filings — .

Companies where HASSAN FRED has traded

BridgeBio Pharma, Inc.9 tx · $273.5K · Jun 24, 2026
PRECIGEN, INC.49 tx · $1.7M · Mar 16, 2026
Cocrystal Pharma, Inc.5 tx · $1.5M · Jan 13, 2026
EyePoint, Inc.3 tx · Jan 6, 2026
8 tx · Jun 16, 2023
8 tx · $501.6K · May 7, 2020
48 tx · $1M · Jun 18, 2018
2 tx · $5M · Sep 3, 2013
15 tx · $395.5K · May 7, 2012
49 tx · $16M · Nov 4, 2009

Track record of HASSAN FRED

Statistical track record

Free account

Open-market buys: 27

Last buy: Aug 14, 2023

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of HASSAN FRED

Co-insiders of HASSAN FRED

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
BridgeBio Pharma, Inc.Listing on record	Jun 24, 2026	AwardD (derivative)	5,277	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BridgeBio Pharma, Inc.Listing on record	Jun 24, 2026	Award	3,990	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
PRECIGEN, INC.Listing on record	Mar 16, 2026	Exercise	71,839	—	n/a (No price was disclosed in the filing)		SEC
PRECIGEN, INC.Listing on record	Mar 16, 2026	ExerciseD (derivative)	-71,839	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
PRECIGEN, INC.Listing on record	Mar 12, 2026	AwardD (derivative)	41,073	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
PRECIGEN, INC.Listing on record	Mar 12, 2026	Award	17,948	3.51 USD	$63K		SEC
PRECIGEN, INC.Listing on record	Mar 12, 2026	AwardD (derivative)	35,612	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Cocrystal Pharma, Inc.Listing on record	Jan 13, 2026	AwardD (derivative)	16,410	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
EyePoint, Inc.Listing on record	Jan 6, 2026	AwardD (derivative)	40,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Cocrystal Pharma, Inc.Listing on record	Oct 30, 2025	AwardD (derivative)	719,426	1.39 USD	$1M	Unusual size	SEC
Cocrystal Pharma, Inc.Listing on record	Oct 30, 2025	Award	359,713	1.39 USD	$500K	Unusual size	SEC
BridgeBio Pharma, Inc.Listing on record	Jun 24, 2025	AwardD (derivative)	8,425	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BridgeBio Pharma, Inc.Listing on record	Jun 24, 2025	Award	6,589	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
PRECIGEN, INC.Listing on record	Mar 17, 2025	AwardD (derivative)	71,839	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
PRECIGEN, INC.Listing on record	Mar 17, 2025	Exercise	87,412	—	n/a (No price was disclosed in the filing)		SEC
PRECIGEN, INC.Listing on record	Mar 17, 2025	ExerciseD (derivative)	-87,412	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
PRECIGEN, INC.Listing on record	Mar 17, 2025	AwardD (derivative)	83,517	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
PRECIGEN, INC.Listing on record	Mar 17, 2025	Award	36,206	1.74 USD	$63K	Unusual size	SEC
EyePoint, Inc.Listing on record	Jan 7, 2025	AwardD (derivative)	40,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Cocrystal Pharma, Inc.Listing on record	Oct 11, 2024	Award	8,067	—	n/a (No price was disclosed in the filing)		SEC
EyePoint, Inc.Listing on record	Sep 5, 2024	AwardD (derivative)	60,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BridgeBio Pharma, Inc.Listing on record	Jun 25, 2024	AwardD (derivative)	26,014	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
PRECIGEN, INC.Listing on record	Mar 18, 2024	AwardD (derivative)	101,626	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
PRECIGEN, INC.Listing on record	Mar 18, 2024	AwardD (derivative)	87,412	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
PRECIGEN, INC.Listing on record	Mar 18, 2024	Award	44,055	1.43 USD	$63K	Unusual size	SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
BridgeBio Pharma, Inc.Listing on record	Jun 24, 2026	AwardD (derivative)	5,277	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BridgeBio Pharma, Inc.Listing on record	Jun 24, 2026	Award	3,990	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
PRECIGEN, INC.Listing on record	Mar 16, 2026	Exercise	71,839	—	n/a (No price was disclosed in the filing)		SEC
PRECIGEN, INC.Listing on record	Mar 16, 2026	ExerciseD (derivative)	-71,839	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
PRECIGEN, INC.Listing on record	Mar 12, 2026	AwardD (derivative)	41,073	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
PRECIGEN, INC.Listing on record	Mar 12, 2026	Award	17,948	3.51 USD	$63K		SEC
PRECIGEN, INC.Listing on record	Mar 12, 2026	AwardD (derivative)	35,612	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Cocrystal Pharma, Inc.Listing on record	Jan 13, 2026	AwardD (derivative)	16,410	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
EyePoint, Inc.Listing on record	Jan 6, 2026	AwardD (derivative)	40,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Cocrystal Pharma, Inc.Listing on record	Oct 30, 2025	AwardD (derivative)	719,426	1.39 USD	$1M	Unusual size	SEC
Cocrystal Pharma, Inc.Listing on record	Oct 30, 2025	Award	359,713	1.39 USD	$500K	Unusual size	SEC
BridgeBio Pharma, Inc.Listing on record	Jun 24, 2025	AwardD (derivative)	8,425	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BridgeBio Pharma, Inc.Listing on record	Jun 24, 2025	Award	6,589	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
PRECIGEN, INC.Listing on record	Mar 17, 2025	AwardD (derivative)	71,839	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
PRECIGEN, INC.Listing on record	Mar 17, 2025	Exercise	87,412	—	n/a (No price was disclosed in the filing)		SEC
PRECIGEN, INC.Listing on record	Mar 17, 2025	ExerciseD (derivative)	-87,412	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
PRECIGEN, INC.Listing on record	Mar 17, 2025	AwardD (derivative)	83,517	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
PRECIGEN, INC.Listing on record	Mar 17, 2025	Award	36,206	1.74 USD	$63K	Unusual size	SEC
EyePoint, Inc.Listing on record	Jan 7, 2025	AwardD (derivative)	40,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Cocrystal Pharma, Inc.Listing on record	Oct 11, 2024	Award	8,067	—	n/a (No price was disclosed in the filing)		SEC
EyePoint, Inc.Listing on record	Sep 5, 2024	AwardD (derivative)	60,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BridgeBio Pharma, Inc.Listing on record	Jun 25, 2024	AwardD (derivative)	26,014	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
PRECIGEN, INC.Listing on record	Mar 18, 2024	AwardD (derivative)	101,626	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
PRECIGEN, INC.Listing on record	Mar 18, 2024	AwardD (derivative)	87,412	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
PRECIGEN, INC.Listing on record	Mar 18, 2024	Award	44,055	1.43 USD	$63K	Unusual size	SEC